These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 7714311

  • 21. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP).
    Bertario L, Bandello F, Rossetti C, Sala P, Fortini E, Spinelli P, Gennari L, Pietroiusti M, Presciuttini S.
    Eur J Cancer Prev; 1993 Jan; 2(1):69-75. PubMed ID: 8381318
    [Abstract] [Full Text] [Related]

  • 22. Congenital hypertrophy of the retinal pigment epithelium and APC mutations in Chinese with familial adenomatous polyposis.
    Pang CP, Fan DS, Keung JW, Baum L, Tang NL, Lau JW, Lam DS.
    Ophthalmologica; 2001 Jan; 215(6):408-11. PubMed ID: 11741105
    [Abstract] [Full Text] [Related]

  • 23. Fundus lesions of adenomatous polyposis.
    Tiret A, Parc C.
    Curr Opin Ophthalmol; 1999 Jun; 10(3):168-72. PubMed ID: 10537774
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Molecular and clinical study of familial adenomatous polyposis for genetic testing and management.
    Li G, Tamura K, Yamamoto Y, Sashio H, Utsunomiya J, Yamamura T, Shimoyama T, Furuyama J.
    J Exp Clin Cancer Res; 1999 Dec; 18(4):519-29. PubMed ID: 10746979
    [Abstract] [Full Text] [Related]

  • 27. Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.
    Nusliha A, Dalpatadu U, Amarasinghe B, Chandrasinghe PC, Deen KI.
    BMC Res Notes; 2014 Oct 18; 7():734. PubMed ID: 25326340
    [Abstract] [Full Text] [Related]

  • 28. [Diagnosis of familial adenomatous polyposis].
    Jirásek V.
    Vnitr Lek; 2002 Jun 18; 48(6):552-5. PubMed ID: 12132358
    [Abstract] [Full Text] [Related]

  • 29. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis.
    Berk T, Cohen Z, McLeod RS, Parker JA.
    Dis Colon Rectum; 1988 Apr 18; 31(4):253-7. PubMed ID: 2896112
    [Abstract] [Full Text] [Related]

  • 30. In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review.
    Rehan S, Aye K.
    Clin Exp Ophthalmol; 2020 Jan 18; 48(1):98-116. PubMed ID: 31525261
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ocular manifestations of familial adenomatous polyposis (Gardner syndrome).
    Traboulsi EI.
    Ophthalmol Clin North Am; 2005 Mar 18; 18(1):163-6, x. PubMed ID: 15763201
    [Abstract] [Full Text] [Related]

  • 34. [Familial adenomatous polyposis (FAP): integration of clinical and genetic parameters in the screening of subjects at risk. A one-family example].
    Chautems R, Givel JC.
    Swiss Surg; 1996 Mar 18; 2(5):196-200. PubMed ID: 8963844
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome.
    Shields JA, Shields CL, Shah PG, Pastore DJ, Imperiale SM.
    Ophthalmology; 1992 Nov 18; 99(11):1709-13. PubMed ID: 1333580
    [Abstract] [Full Text] [Related]

  • 37. Study of diagnostic value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients.
    Cai S, Yu Y, Xie X, Huang Y, Song Y, Zhan S, Zheng S.
    Eur J Cancer Prev; 2022 Sep 01; 31(5):422-429. PubMed ID: 35191403
    [Abstract] [Full Text] [Related]

  • 38. Exceptions to the rule: individuals with FAP specific CHRPE and mutations in exon 6 of the APC gene.
    Pack K, Smith-Ravin I, Phillips RK, Hodgson SV.
    Clin Genet; 1996 Aug 01; 50(2):110-1. PubMed ID: 8937774
    [No Abstract] [Full Text] [Related]

  • 39. Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis.
    Wallis YL, Macdonald F, Hultén M, Morton JE, McKeown CM, Neoptolemos JP, Keighley M, Morton DG.
    Hum Genet; 1994 Nov 01; 94(5):543-8. PubMed ID: 7959691
    [Abstract] [Full Text] [Related]

  • 40. The clinical [corrected] background of familial adenomatous polyposis. History, epidemiology, diagnosis and treatment.
    Kartheuser A, Detry R, West S, Coppens JP, Gribomont AC, Hoang P, Melange M, Vanheuverzwyn R, Verellen-Dumoulin C, Burn J.
    Acta Gastroenterol Belg; 1995 Nov 01; 58(2):252-66. PubMed ID: 7571988
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.